Literature DB >> 25540903

Cationic micelle delivery of Trp2 peptide for efficient lymphatic draining and enhanced cytotoxic T-lymphocyte responses.

Qin Zeng1, Hao Jiang1, Ting Wang1, Zhirong Zhang1, Tao Gong1, Xun Sun2.   

Abstract

Neutral particles 20-45 nm in diameter showed potential as tumor antigen vectors because they targeted the draining lymph nodes after subcutaneous injection. However, they were weakly immune-stimulatory and could also spread throughout the body, raising the risk of systemic toxicity. Here we explored whether incorporating positively charged amphiphilic polymers into micelles improves their site specificity and immunogenicity. Cationic polyethylenimine (2k)-stearic acid (PSA) micelles were loaded with the melanoma antigen peptide Trp2; they showed an average size of 28.7±8.2 nm and an encapsulation efficiency of 99.21±5.38%. Empty PSA micelles acted as a robust adjuvant in vitro, promoting maturation, proliferation and migration of bone marrow-derived dendritic cells in a dose-dependent manner. After subcutaneous injection into mice, Trp2-loaded PSA micelles accumulated preferentially in the medulla and paracortex of the draining lymph nodes and were present at negligible levels in the systemic circulation. Mice immunized with Trp2-loaded PSA micelles showed significantly higher Trp2-specific cytotoxic T lymphocyte activity than mice immunized with free Trp2 or a mixture of Trp2 and empty PSA micelles. In a B16-F10 murine melanoma model, Trp2-loaded PSA micelles inhibited tumor growth significantly more than did free Trp2 and PSA micelles caused less systemic toxicity. These findings suggest that cationic PSA micelles loaded with Trp2 may be a potential approach for melanoma immunotherapy.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cationic micelle; Cytotoxic T lymphocytes; Draining lymph node; Polyethylenimine; Trp2 antigen peptide

Mesh:

Substances:

Year:  2014        PMID: 25540903     DOI: 10.1016/j.jconrel.2014.12.024

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  22 in total

Review 1.  Biomaterials for vaccine-based cancer immunotherapy.

Authors:  Rui Zhang; Margaret M Billingsley; Michael J Mitchell
Journal:  J Control Release       Date:  2018-10-09       Impact factor: 9.776

Review 2.  From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.

Authors:  Natalie L Trevaskis; Lisa M Kaminskas; Christopher J H Porter
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

Review 3.  Modulating the immune system through nanotechnology.

Authors:  Tamara G Dacoba; Ana Olivera; Dolores Torres; José Crecente-Campo; María José Alonso
Journal:  Semin Immunol       Date:  2017-10-09       Impact factor: 11.130

Review 4.  Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges.

Authors:  Katharina Maisel; Maria Stella Sasso; Lambert Potin; Melody A Swartz
Journal:  Adv Drug Deliv Rev       Date:  2017-07-08       Impact factor: 15.470

5.  Engineering drug delivery systems to overcome mucosal barriers for immunotherapy and vaccination.

Authors:  Jacob C McCright; Katharina Maisel
Journal:  Tissue Barriers       Date:  2019-11-28

Review 6.  Targeting Lymphatics for Nanoparticle Drug Delivery.

Authors:  Jacob McCright; Ritika Naiknavare; Jenny Yarmovsky; Katharina Maisel
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

7.  Nanoparticles with dense poly(ethylene glycol) coatings with near neutral charge are maximally transported across lymphatics and to the lymph nodes.

Authors:  Jacob McCright; Colin Skeen; Jenny Yarmovsky; Katharina Maisel
Journal:  Acta Biomater       Date:  2022-04-02       Impact factor: 10.633

8.  Optimum Preparation Method for Self-Assembled PEGylation Nano-Adjuvant Based on Rehmannia glutinosa Polysaccharide and Its Immunological Effect on Macrophages.

Authors:  Yee Huang; Li Nan; Chenwen Xiao; Quanan Ji; Ke Li; Qiang Wei; Yan Liu; Guolian Bao
Journal:  Int J Nanomedicine       Date:  2019-11-29

Review 9.  Micelle-Based Adjuvants for Subunit Vaccine Delivery.

Authors:  Thomas Trimaille; Bernard Verrier
Journal:  Vaccines (Basel)       Date:  2015-09-25

Review 10.  Improving the clinical impact of biomaterials in cancer immunotherapy.

Authors:  Joshua M Gammon; Neil M Dold; Christopher M Jewell
Journal:  Oncotarget       Date:  2016-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.